Literature DB >> 10226093

Calcium channel blockers activate the interleukin-6 gene via the transcription factors NF-IL6 and NF-kappaB in primary human vascular smooth muscle cells.

O Eickelberg1, M Roth, R Mussmann, J J Rüdiger, M Tamm, A P Perruchoud, L H Block.   

Abstract

BACKGROUND: Calcium channel blockers (CCB) of all subclasses: the dihydropyridines, benzothiazepines, and phenylalkylamines, at nanomolar concentrations, have been shown to up-regulate interleukin-6 (IL-6) mRNA. We investigated the underlying molecular mechanism responsible for IL-6 induction in response to the CCB amlodipine, diltiazem, and verapamil in primary human vascular smooth muscle cells (VSMC). METHODS AND
RESULTS: All 3 CCB directly activated transcription of the human IL-6 gene in primary human VSMC in a time- and dose-dependent manner, as demonstrated by luciferase reporter gene assays using a 651-bp fragment of the human IL-6 gene promoter. Deletion analysis of the IL-6 promoter revealed that CCB inducible promoter activity was localized to a 160-bp fragment directly upstream of the transcriptional start site of the IL-6 gene. Known transcription factor consensus sequences within this fragment include a NF-IL6 and a NF-kappaB site. Site-directed mutagenesis suggested that both transcription factors had positive regulatory activity and cooperatively transmitted induction of the IL-6 gene by CCB. The data are confirmed by electrophoretic mobility shift analyses using nuclear extracts from CCB-stimulated and control primary VSMC. CCB of all subclasses increased DNA binding of NF-IL6 and NF-kappaB as early as 30 minutes after stimulation with the drugs. This effect was independent of intracellular calcium concentrations because calcium-free medium did not increase NF-IL6 or NF-kappaB activity.
CONCLUSIONS: The results demonstrate that CCB of all 3 subclasses are capable of activating NF-IL6 and NF-kappaB. CCB may thus directly regulate cellular functions by affecting the activity of transcription factors independent of changes of intracellular calcium concentrations, an observation that is of interest considering the biological effects induced by CCB.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10226093     DOI: 10.1161/01.cir.99.17.2276

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

1.  Verapamil stereoisomers induce antiproliferative effects in vascular smooth muscle cells via autophagy.

Authors:  Joshua K Salabei; Arun Balakumaran; Justin C Frey; Paul J Boor; Mary Treinen-Moslen; Daniel J Conklin
Journal:  Toxicol Appl Pharmacol       Date:  2012-05-22       Impact factor: 4.219

2.  Matrix metalloproteinases and cardiovascular diseases.

Authors:  A Papazafiropoulou; N Tentolouris
Journal:  Hippokratia       Date:  2009-04       Impact factor: 0.471

3.  Homocysteine stimulates nuclear factor kappaB activity and monocyte chemoattractant protein-1 expression in vascular smooth-muscle cells: a possible role for protein kinase C.

Authors:  G Wang; Y L Siow; K O
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

4.  Effects of verapamil and nifedipine on different parameters in lipopolysaccharide-induced septic shock.

Authors:  Basar Sirmagul; Fatma Sultan Kilic; Ozgül Tunc; Engin Yildirim; Kevser Erol
Journal:  Heart Vessels       Date:  2006-05       Impact factor: 2.037

5.  BMP type II receptor deficiency confers resistance to growth inhibition by TGF-β in pulmonary artery smooth muscle cells: role of proinflammatory cytokines.

Authors:  Rachel J Davies; Alan M Holmes; John Deighton; Lu Long; Xudong Yang; Lucy Barker; Christoph Walker; David C Budd; Paul D Upton; Nicholas W Morrell
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-01-06       Impact factor: 5.464

6.  Macrophages exposed continuously to lipopolysaccharide and other agonists that act via toll-like receptors exhibit a sustained and additive activation state.

Authors:  D A Hume; D M Underhill; M J Sweet; A O Ozinsky; F Y Liew; A Aderem
Journal:  BMC Immunol       Date:  2001-10-12       Impact factor: 3.615

7.  Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertension.

Authors:  Laura C Price; Gaetano Caramori; Frederic Perros; Chao Meng; Natalia Gambaryan; Peter Dorfmuller; David Montani; Paolo Casolari; Jie Zhu; Konstantinos Dimopoulos; Dongmin Shao; Barbara Girerd; Sharon Mumby; Alastair Proudfoot; Mark Griffiths; Alberto Papi; Marc Humbert; Ian M Adcock; S John Wort
Journal:  PLoS One       Date:  2013-10-04       Impact factor: 3.240

8.  N-n-butyl haloperidol iodide ameliorates cardiomyocytes hypoxia/reoxygenation injury by extracellular calcium-dependent and -independent mechanisms.

Authors:  Yanmei Zhang; Gaoyong Chen; Shuping Zhong; Fuchun Zheng; Fenfei Gao; Yicun Chen; Zhanqin Huang; Wenfeng Cai; Weiqiu Li; Xingping Liu; Yanshan Zheng; Han Xu; Ganggang Shi
Journal:  Oxid Med Cell Longev       Date:  2013-11-12       Impact factor: 6.543

9.  Depletion of T-cell intracellular antigen proteins promotes cell proliferation.

Authors:  Raquel Reyes; José Alcalde; José M Izquierdo
Journal:  Genome Biol       Date:  2009-08-26       Impact factor: 13.583

10.  Markers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study.

Authors:  Anna Gluba-Brzózka; Marta Michalska-Kasiczak; Beata Franczyk; Marek Nocuń; Peter Toth; Maciej Banach; Jacek Rysz
Journal:  Lipids Health Dis       Date:  2016-02-03       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.